The pathology and management of endocervical glandular neoplasia

International Journal of Gynecological Cancer

Volumn 15, Issue 4, 2005, Pages 583-592

  El Ghobashy, A A ^a   Shaaban, A M ^b   Herod, J ^c   Herrington, C Simon ^d  

^a BRADFORD ROYAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Cervical; Glandular; Pathology; Treatment

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADENOCARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURGERY; CLEAR CELL CARCINOMA; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOSIS; FEMALE FERTILITY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; HYSTERECTOMY; MESONEPHROMA; MUCINOUS CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX GLANDULAR INTRAEPITHELIAL NEOPLASIA;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYSTERECTOMY; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 22544461609     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00113.x     Document Type: Review

References (72)

1. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.
2. Stockton D, Cooper P, Lonsdale RN. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J Med Screen 1997;4:40-3.
3. Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur J Obstet Gynecol Reprod Biol 2002;101:64-9.
4. Evans D, Hudson E, Brown C. Terminology in gynaecological cytopathology report of the working party of the BSCC. J Clin Pathol 1986;39:933-44.
5. NHSCSP. Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology. NHSCSP publication 1, 2000.
6. Solomon D, Davy D, Kurman R et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-8.
7. Desai M. An update on terminology in cervical smears. CPD Cellular Pathology 2003;5:18-21.
8. Tavassoli FA, Hoefler H, Holland R et al. Tumours of uterine cervix. In: Tavassoli FA, Devilee P, eds. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
9. NHSCSP. Histopathology reporting in cervical screening. Sheffield: Working party of the Royal College of Pathologists and the NHS Cervical Screening Programme, 1999:16-24.
10. Ostor AG, Pagano R, Davoren RA, Fortune DW, Chanen W, Rome R. Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 1984;3:179-90.
11. Park JJ, Sun D, Quade BJ et al. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol 2000;24:1414-9.
12. Ostor AG. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2000;19:29-38.
13. FIGO. Modifications in the staging for stage I vulvar and stage I cervical cancer. Report of the FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 1995;50:215-6.
14. Fluhmann CF. Focal hyperplasis (tunnel clusters) of the cervix uteri. Obstet Gynecol 1961;17:206-14.
15. Qizilbash AH. In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol 1975;64: 155-70.
16. Teshima S, Shimosato Y, Kishi K, Kasamatsu T, Ohmi K, Uei Y. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis. Cancer 1985;56:167-72.
17. Rollason TP, Cullimore J, Bradgate MG. A suggested columnar cell morphological equivalent of squamous carcinoma in situ with early stromal invasion. Int J Gynecol Pathol 1989;8:230-6.
18. Matsukuma K, Tsukamoto N, Kaku T et al. Early adenocarcinoma of the uterine cervix-its histologic and immunohistologic study. Gynecol Oncol 1989;35:38-43.
19. Kaku T, Kamura T, Sakai K et al. Early adenocarcinoma of the uterine cervix. Gynecol Oncol 1997;65:281-5.
20. Ostor A, Rome R, Quinn M. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol 1997;89:88-93.
21. Nicklin JL, Perrin LC, Crandon AJ, Ward BG. Microinvasive adenocarcinoma of the cervix. Aust N Z J Obstet Gynaecol 1999;39:411-3.
22. Schorge JO, Lee KR, Flynn CE, Goodman A, Sheets EE. Stage IA1 cervical adenocarcinoma: definition and treatment. Obstet Gynecol 1999;93:219-22.
23. Kurian K, al-Nafussi A. Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: a study of 121 cases. J Clin Pathol 1999;52:112-7.
24. Dabbs DJ, Sturtz K, Zaino RJ. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996;27:172-7.
25. Gilks CB, Clement PB. Papillary serous adenocarcinoma of the uterine cervix: a report of three cases. Mod Pathol 1992;5:426-31.
26. Zhou C, Gilks CB, Hayes M, Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol 1998;22:113-20.
27. Ferry JA, Scully RE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol 1990;14:1100-11.
28. McCluggage WG, Oliva E, Herrington CS, McBride H, Young RH. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003;43:144-50.
29. McCluggage WG, Maxwell P. bcl-2 and p21 immunostaining of cervical tubo-endometrial metaplasia. Histopathology 2002;40:107-8.
30. Cameron RI, Maxwell P, Jenkins D, McCluggage WG. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002;41:313-21.
31. Jackson SR, Hollingworth TA, Anderson MC, Johnson J, Hammond RH. Glandular lesions of the cervix-cytological and histological correlation. Cytopathology 1996;7:10-6.
32. Cina SJ, Richardson MS, Austin RM, Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10:176-80.
33. Zaino RJ. Glandular lesions of the uterine cervix. Mod Pathol 2000;13:261-74.
34. Brown LJ, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 1986;39:22-8.
35. Casper GR, Ostor AG, Quinn MA. A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol 1997;64:166-70.
36. Goldstein NS, Ahmad E, Hussain M, Hankin RC, Perez-Reyes N. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol 1998;110:200-9.
37. Pirog EC, Kleter B, Olgac S et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000;157: 1055-62.
38. Brinton LA, Tashima KT, Lehman HF et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987;47: 1706-11.
39. Ursin G, Peters RK, Henderson BE, d'Ablaing G 3rd, Monroe KR, Pike MC. Oral contraceptive use and adenocarcinoma of cervix. Lancet 1994;344:1390-4.
40. El-Ghobashy A, Shaaban A, Herod J, Innes J, Prime W, Herrington CS. Overexpression of cyclin A and Cyclin B as markers of neoplastic glandular lesions of the cervix. Gynecol Oncol 2004;92:628-34.
41. Kamoi S, Aljuboury MI, Akin MR, Silverberg SG. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol 2002;21:217-23.
42. Laverty CR, Farnsworth A, Thurloe J, Bowditch R. The reliability of a cytological prediction of cervical adenocarcinoma in situ. Aust N Z J Obstet Gynaecol 1988; 28:307-12.
43. Leeson SC, Inglis TC, Salman WD. A study to determine the underlying reason for abnormal glandular cytology and the formulation of a management protocol. Cytopathology 1997;8:20-6.
44. Waddell CA. Glandular abnormalities: dilemmas in cytological prediction and clinical management. Cytopathology 1997;8:27-30.
45. Shin CH, Schorge JO, Lee KR, Sheets EE. Cytologic and biopsy findings leading to conization in adenocarcinoma in situ of the cervix. Obstet Gynecol 2002;100:271-6.
46. Valente PT, Schantz HD, Schultz M. Cytologic atypia associated with microglandular hyperplasia. Diagn Cytopathol 1994;10:326-31.
47. Lee KR, Manna EA, St John T. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn Cytopathol 1995;13:202-8.
48. Ng AB, Teeple D, Lindner EA, Reagan JW. The cellular manifestations of extrauterine cancer. Acta Cytol 1974;18: 108-17.
49. Bertrand M, Lickrish GM, Colgan TJ. The anatomic distribution of cervical adenocarcinoma in situ: implications for treatment. Am J Obstet Gynecol 1987;157:21-5.
50. Lickrish GM, Colgan TJ, Wright VC. Colposcopy of adenocarcinoma in situ and invasive adenocarcinoma of the cervix. Obstet Gynecol Clin North Am 1993;20: 111-22.
51. Luesley DM, Jordan JA, Woodman CB, Watson N, Williams DR, Waddell C. A retrospective review of adenocarcinoma-in-situ and glandular atypia of the uterine cervix. Br J Obstet Gynaecol 1987;94:699-703.
52. Cullimore JE, Luesley DM, Rollason TP et al. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN) - a preliminary report. Br J Obstet Gynaecol 1992; 99:314-8.
53. Ostor AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol 2000;79:207-10.
54. Nicklin JL, Wright RG, Bell JR, Samaratunga H, Cox NC, Ward BG. A clinicopathological study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Aust N Z J Obstet Gynaecol 1991;31:179-83.
55. Shin CH, Schorge JO, Lee KR, Sheets EE. Conservative management of adenocarcinoma in situ of the cervix. Gynecol Oncol 2000;79:6-10.
56. Lea JS, Shin CH, Sheets EE et al. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ. Gynecol Oncol 2002;87:129-32.
57. Widrich T, Kennedy AW, Myers TM, Hart WR, Wirth S. Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynecol Oncol 1996;61:304-8.
58. Denehy TR, Gregori CA, Breen JL. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997;90:1-6.
59. Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-64.
60. Kennedy AW, elTabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995;58:274-7.
61. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol 1996;88: 82-6.
62. McHale MT, Le TD, Burger RA, Gu M, Rutgers JL, Monk BJ. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet Gynecol 2001;98:726-31.
63. Kennedy AW, Biscotti CV. Further study of the management of cervical adenocarcinoma in situ. Gynecol Oncol 2002;86:361-4.
64. Prendiville W, Cullimore J, Norman S. Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1989;96:1054-60.
65. Luesley DM, Cullimore J, Redman CW et al. Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. BMJ 1990;300: 1690-3.
66. Bigrigg A, Haffenden DK, Sheehan AL, Codling BW, Read MD. Efficacy and safety of large-loop excision of the transformation zone. Lancet 1994;343:32-4.
67. Cruickshank ME, Flannelly G, Campbell DM, Kitchener HC. Fertility and pregnancy outcome following large loop excision of the cervical transformation zone. Br J Obstet Gynaecol 1995;102:467-70.
68. Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Adenocarcinoma in situ of the cervix: management and outcome. Gynecol Oncol 1999;73:348-53.
69. Buscema J, Woodruff JD. Significance of neoplastic atypicalities in endocervical epithelium. Gynecol Oncol 1984;17:356-62.
70. Muntz HG, Bell DA, Lage JM, Goff BA, Feldman S, Rice LW. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol 1992;80:935-9.
71. Soutter WP, Haidopoulos D, Gornall RJ et al. Is conservative treatment for adenocarcinoma in situ of the cervix safe? BJOG 2001;108:1184-9.
72. Krivak TC, Retherford B, Voskuil S, Rose GS, Alagoz T. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ. Gynecol Oncol 2000;77:334-5.